LNSR NASDAQ
LENSAR, Inc.
1W: -1.4%
1M: +4.5%
3M: -48.8%
YTD: -50.0%
1Y: -58.9%
3Y: +128.3%
5Y: -25.3%
$5.88
+0.08 (+1.38%)
After Hours: $5.86 (-0.02, -0.43%)
Weekly Expected Move ±8.4%
$5
$5
$6
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$70.2M
52W Range5.06-14.16
Volume76,252
Avg Volume120,793
Beta0.84
Dividend—
Analyst Ratings
Company Info
CEONicholas T. Curtis
Employees140
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-10-02
Websitelensar.com
2800 Discovery Drive
Orlando, FL 32826
US
Orlando, FL 32826
US
888 536 7271
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Latest News
LENSAR signals 2027 as “really, really good” year as it rebuilds distributor orders after Alcon deal termination
LENSAR GAAP EPS of $0.00 misses by $0.18, revenue of $13.4M in-line
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| CURTIS NICHOLAS T | J-Other | 0 | — | 2026-05-06 |
| Connaughton Alan B. | F-InKind | 2,739 | $5.38 | 2026-05-06 |
| STAAB THOMAS R II | F-InKind | 1,350 | $5.38 | 2026-05-06 |
| Wong Kendra | F-InKind | 864 | $5.38 | 2026-05-06 |
| STAAB THOMAS R II | M-Exempt | 5,500 | $2.65 | 2026-03-19 |